Designs for Health Magnesium Buffered Chelate uses Albion's TRAACS bisglycinate for high-bioavailability cellular delivery, while Metagenics Mag Glycinate uses a comparable albion-licensed chelate at slightly lower elemental dosing. DFH wins on per-capsule elemental loading; Metagenics wins on formulation simplicity. SupplementPractice.com lets practitioners toggle between them in the same patient chart.
DFH Magnesium Buffered Chelate vs. Metagenics Mag Glycinate
| Spec | DFH Buffered Chelate | Metagenics Mag Glycinate |
|---|---|---|
| Form | TRAACS bisglycinate (Albion) | Albion-licensed glycinate |
| Elemental / cap | ~200 mg | ~120–240 mg |
| Buffer | Yes (di-magnesium malate) | No |
| Best for | Cellular Mg loading | Sleep / GI tolerance |
| Practitioner pick | Aggressive cellular support | Routine foundation |
Bioavailability Comes From Chelate Form, Not Brand Loyalty
Both products use Albion-licensed chelates with strong human bioavailability data. The difference is dose, buffer, and excipient preference. Practitioners use DFH when they want aggressive cellular Mg loading and Metagenics when they want a clean glycinate without buffer.
Why Toggle in SupplementPractice.com, Not a Manual Portal
Toggling magnesium chelates between two practitioner brands manually means two logins, two carts, two invoices. SupplementPractice.com keeps both catalogs in the same patient chart and lets the AI Clinical Co-Pilot suggest the right one based on inventory and tolerance notes.
